SPARTA Biodiscovery operates in life sciences, biotechnology and pharmaceutical analytics, specialising in nanoparticle and nanoformulation characterisation. Its core SPARTA® technology, Single Particle Automated Raman Trapping Analysis, enables label-free, automated analysis of individual nanoparticles, providing information on size, chemical composition, heterogeneity and stability. The company offers analytical services and a benchtop instrument for researchers and developers working on nanomedicines, drug delivery systems, viral vectors, exosomes, vaccines and gene therapies. Its services support research, process development, troubleshooting and quality control, helping pharmaceutical, biotech and academic partners better understand and optimise next-generation therapeutic formulations.